G. Walmsley Graham, Director at Olema Pharmaceuticals, Inc. (OLMA), bought 2,343,114 shares at $19.00 ($22.0M) on 2020-11-23, disclosed to the SEC on 2020-11-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,183,114 | $0 | 0.0% |
| 2 | $19.00 | 1,160,000 | $22.0M | 100.0% |
| Total | $9.41 avg | 2,343,114 | $22.0M | 100% |
| Filing → |
| OLMA | BUY | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | SELL | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-17 | $4.7M | — | Filing → |